IRCT20190831044653N1 IRCT 2019-09-24 Bojnourd University of Medical Sciences Dexamethasone in treatment of acute renal colic Intravascular dexamethasone plus ketorolac compare with ketorolac alone for treatment of acute renal colic: a randomized clinical trial 2019-09-23 anticipated 120 Complete https://irct.ir/trial/41834 interventional Randomization: Randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Based on the result of randomization by Permuted Block Randomization and individually with R software , patients are allocated to groups sequentially. Drugs in prefilled syringes with unmeaning code for doctor will be introduced to him. Both patient and doctor are blinded about the allocation and the composition of the drugs, Blinding description: Drugs (ketorolac plus placebo OR ketorolac plus dexamethason) are administrated via prefilled and separated syringes with no details. Doctors, patients and analyzer don't know which groups the patients are. Two groups are nominated A or B. N/A colic. Intervention 1: Intervention group: Ketorolac (30mg/1ml), produced in Iran (30 mg, single dose, intravenous) plus Dexamethasone (8mg/2ml), produced in Iran (8 mg, single dose, intravenous). Intervention 2: Control group: Ketorolac (30mg/1ml), produced in Iran, (30 mg, single dose, intravenous) plus sterile distilled water for injection, produced in Iran (1ml, single dose, intravenous). Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There is no more information.